Dong-a St Co., Ltd.
Clinical trials sponsored by Dong-a St Co., Ltd., explained in plain language.
-
New Triple-Threat drug combo aims to tame stubborn diabetes
Disease control OngoingThis study is testing if adding a new drug called DA5221-T to two existing diabetes medications helps people with type 2 diabetes who still have high blood sugar. About 174 adults who are already taking the two-drug combo will receive either the new triple therapy or a placebo fo…
Phase: PHASE3 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Drug maker tests if two pills act the same in the body
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if two versions of the same drug, DA-2902 and DA-2902-R, are absorbed by the body in the same way. It will involve 40 healthy adult volunteers who will take a single dose of each drug after eating. The main goal is to compare the levels of the drug in the b…
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC